Glutamatergic afferente of the ventral tegmental area (VTA) play an important role in the functioning of the VTA and are involved in the pathophysiology of drug addiction. It has recently been demonstrated that the VTA is densely innervated by glutamatergic axons and that glutamatergic neurons projecting to the VTA are situated in almost all structures that project there. While the projection from the prefrontal cortex is essentially entirely glutamatergic, subcortical glutamatergic neurons innervating the VTA intermingle with non-glutamatergic, most likely GABAergic and/or peptidergic VTAprojecting neurons. The first part of this review focuses on the origins and putative functional implications of various glutamatergic projections to the VTA. In the second part we consider how different neuropeptides via different mechanisms modulate glutamatergic actions in the VTA. We conclude by developing a model of how the glutamatergic afferents might together contribute to the functions of the VTA.
INTRODUCTION
The ventral tegmental area (VTA), from which the mesocorticolimbic projection system originates, contains dopaminergic, GABAergic, and glutamatergic neurons /31,55,100,118,153,182/. VTA dopaminergic neurons have been strongly implicated in the CNS mediation of the rewarding effects of direct electrical stimulation of the brain /28,47,51, 101,134/ and of several drugs of abuse /13,29,34, 35,64,81,84,85,127,188 / and appear to be implicated in the rewarding effects of food /86,87,176,177, 178,179/, water /62/, and sexual interaction as well /42,126/. Although little is known about the functions of VTA GABAergic and glutamatergic neurons, one might speculate that their projections and interactions with dopaminergic neurons and each other are also essential to the functional potency of the VTA. Dopamine neurons change their firing from irregular single spike firing to high frequency burst activity in response to unpredicted, biologically salient events and cues that predict rewards /27,124,141/. High frequency burst activity is thought to cause a pronounced spatial and temporal summation of extracellular dopamine in the target areas of these neurons 111, e.g. in the nucleus accumbens and olfactory tubercle 12,22, 45,65/ , that is associated with approach and instrumental responses /128,148/, consummatory responses /177/, and the stamping in of response habits/36,175/.
Glutamatergic afferents play an important role in the regulation of VTA cell activity and are crucial for the functioning of the VTA. Thus, the induction of the behaviorally relevant burst firing of VTA dopamine neurons depends largely on glutamatergic inputs (reviewed in /94,123,173/). Activation of an excitatory pathway from the prefrontal cortex to the VTA /45,113/ and local infusions of glutamate and glutamate receptor agonists induce burst firing of dopaminergic neurons in vivo /21,93/. In contrast, local infusions of ionotropic glutamate receptor antagonists abolish burst firing /20,21,69/ and produce a highly regular pacemaker-like firing pattern of dopaminergic neurons otherwise observed only in deafferentiated in vitro slice preparations.
Glutamatergic actions in the VTA are also critical to the centrally-mediated effects of drugs of abuse. Self-administration of cocaine and heroin is increased by partial blockade of ionotropic glutamate receptors in the VTA /181,183/, suggesting that stimulation of VTA glutamate receptors contributes to the rewarding properties of these drugs. Synaptic plasticity is observed at glutamatergic synapses in the VTA after a single administration of cocaine, amphetamine, ethanol, nicotine or morphine, but not psychoactive substances lacking abuse potential Π, 39,107,136,140,165/ (see also reviews by Kauer /98/ and Kauer and Malenka 1991) . Although the behavioral consequences of such drug-elicited increases in glutamatergic synaptic strength are not yet fully understood, the data suggest that plasticity at excitatory synapses on dopaminergic neurons may be a key neural adaptation contributing to addiction. Blockade of ionotropic glutamate receptors in the VTA prevents the acquisition of associations relating environmental cues to cocaine ΠΜ and morphine /73/. Blockade of VTA glutamate receptors also prevents the development of behavioral sensitization 1951, a progressive and enduring enhancement of drugelicited responses following repeated drug administrations that reflects drug-elicited adaptations of cellular functions. Interestingly, increased expression of various ionotropic glutamate receptor subunits is observed in the VTA following repeated administrations of cocaine, morphine, alcohol or nicotine /43,110,122,171/. Insofar as overexpression of the AMPA (a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor subunit GLuRl in the VTA by viral-mediated gene transfer induces behavioral sensitization to morphine /17/, the observed upregulations of glutamate receptor subunit expression and increased sensitivity of glutamate receptors in the VTA following repeated drug administrations /10,63,174,189/ may be part of the neuroadaptations that contribute to the induction or expression of behavioral sensitization.
Neuroadaptations of glutamatergic afferents of the VTA apparently also play an important role in drug seeking behavior. You et al. /183/ observed that the initiation of cocaine self-administration is accompanied by release of glutamate in the VTA in cocaine experienced rats. This is conditioned glutamate release, as it is seen in cocaine-experienced but not in cocaine-naive animals and is seen in experienced animals (rats previously trained to selfadminister the drug) whether they receive the expected cocaine or, rather, receive unexpected saline for lever-pressing. The VTA glutamate release is also seen in animals given yoked injections of cocaine, but only if the animals have previously been trained to self-administer cocaine themselves. Importantly, intra-VTA glutamate release /183/ or infusions of the glutamate agonist NMDA (Nmethyl-D-aspartate) into the VTA /168/ are sufficient to reinstate cocaine-seeking in animals that have undergone prolonged extinction after initial cocaine self-administration training. Neuroadaptations of glutamatergic terminals that result in increased glutamate release in the VTA are critically involved in stress-induced relapse to cocaine /169/. Footshock stress causes the release of corticotropin releasing factor (CRF), but not glutamate or dopamine in the VTA of cocainenaive animals /169/. In contrast, in cocaineexperienced animals, footshock stress causes the release of CRF in the VTA, which causes local glutamate release, and, in turn, dendritic dopamine release, a marker of dopaminergic activation /103/, and reinstatement of cocaine seeking behavior /169/. Stress-induced reinstatement of cocaineseeking is severely attenuated if ionotropic glutamate receptors in the VTA are blocked /169/. Similarly, drug-induced reinstatement of cocaineand cue-induced reinstatement of heroin seeking are prevented by infusions of glutamate receptor antagonists into the VTA /150,168/ and blockade of VTA glutamate release /12/.
Given the importance of glutamatergic afferents to the functioning of the VTA, the identification of such afferents has received considerable attention in recent years. We review below the origins and putative functional implications of glutamatergic pathways to the VTA and how glutamatergic actions in the VTA are modulated by neuropeptides. We conclude by proposing a model of how the glutamatergic afferents might together contribute to the functions of the VTA. Afferents expressing VGLUT2 arise from almost all subcortical structures that project to the VTA /55/ (Fig. 1) . Notable exceptions are the nucleus accumbens and lateral septum that project to the VTA, but do not contain glutamatergic VTAprojecting neurons, and the dorsal raphe, which contains VGLUT3-, but not VGLUT2-expressing VTA-projecting neurons (Fig. 1) . A common feature of subcortical structures containing VGLUT2-expressing VTA-projecting neurons is that they contain more non-glutamatergic than glutamatergic VTA-projecting neurons ( Fig. 1) and that the glutamatergic VTA-projecting neurons are intermingled with non-glutamatergic VTA-projecting neurons. In the following paragraphs we first discuss VGLUT2-containing pathways to the VTA originating in the forebrain and then those that ascend from the brainstem. Afferents arising in individual structures will be described in order of decreasing "robustness'. The greatest number of VGLUT2-expressing neurons projecting to the VTA is found in the lateral hypothalamus /55/, which consists of two major divisions, the lateral preoptic area and the lateral hypothalamic area. About 15% of all VGLUT2-expressing neurons projecting to the VTA are situated in the lateral hypothalamic area and another 8% or so in the more rostral lateral preoptic area. While the hypothalamus gives rise to a strong subcortical glutamatergic projection to the VTA, how much hypothalamic afferents contribute to VTA activation is largely unknown. Recent interest has been stimulated by the discovery of orexinergic neurons in the lateral hypothalamus, a majority of which co-expresses VGLUT2 /133/. Orexin plays an important role in arousal, feeding, and appetitive behaviors /33,137/. Orexinergic input to the VTA has been implicated in reward-(food) and drug-(morphine) seeking behaviors /72,74,114/ and in the induction of synaptic plasticity at glutamatergic synapses on dopamine neurons leading to behavioral sensitization to cocaine /ll/. Insofar as some orexinergic fibers in the VTA exhibit asymmetrical (putative excitatory) synapses ß/, it is conceivable that glutamate and orexin are co-released from the same axon terminals in the VTA and, thus, that lateral hypothalamic glutamate and orexin act in concert in the VTA. However, the orexinergic-glutamatergic projection probably respresents only a small portion of the glutamate input from the lateral hypothalamus to the VTA, because (i) anatomical studies have identified only a few orexinergic fibers in the VTA /3,38/, and (ii) orexinergic VTA-projecting neurons are restricted to a small part of the lateral hypothalamic area /38/, whereas glutamatergic VTAprojecting neurons are scattered throughout the entire rostro-caudal extent of the lateral hypothalamus, including the lateral preoptic area 1551.
FUNCTIONAL ANATOMY OF GLUTAMATERGIC
Although the lateral habenula is a relatively small brain structure, it contains about 7% of all VGLUT2-expressing VTA-projecting neurons in the rat 1551. The glutamatergic projection from the lateral habenula is of particular interest because available evidence suggests that it may inhibit VTA dopaminergic neurons via activation of GABAergic neurons. It has been shown in an fMRI behavioral study in healthy humans that negative feedback in a motion prediction task activates the habenula, whereas positive feedback activates the ventral striatum, the main recipient of VTA dopaminergic projections /163/. Based on these findings it was suggested that the habenula plays an important role in the control of the human reward system by conveying negative reward information to the VTA /163/. These findings in humans are in good accord with an electrophysiological study in monkeys demonstrating that the activity of lateral habenula neurons is increased in unrewarded trials and decreased in rewarded trials / 112/. The activation of lateral habenular neurons preceded the inhibition of dopamine neurons, suggesting that the lateral habenula inhibits dopamine neurons in the VTA. Indeed, electrical stimulation of the lateral habenula in the rat almost completely suppresses the activity of mesencephalic dopamine neurons /24,89/. The response is mediated, at least in part, by GABAA receptors expressed on dopaminergic neurons, because intra-VTA application of a GABA a antagonist attenuates the lateral habenula induced inhibition of dopaminergic neurons /89/. Insofar as the inhibition of dopamine neurons after stimulation of the lateral habenula is a short-latency response /89/ and GABAergic VTA neurons have been shown to inhibit neighboring dopaminergic neurons /92/, Ji and Shepard /89/ speculated that the glutamatergic projection from the lateral habenula must contact largely GABAergic VTA neurons. Such a projection has been identified recently by Brinschwitz et al. /14/ who showed that VGLUT2-positive axons from the lateral habenula terminate in the VTA mainly on GABAergic neurons (but see 151) . A dense projection from the lateral habenula to a collection of GABAergic neurons that is situated in the ventromedial mesopontine tegmentum just caudal to the VTA and projects robustly to the VTA /56,88/ may also contribute to the short-latency, strong inhibitory effect of lateral habenula stimulation on dopamine neurons.
The ventral pallidum contains another 7% of all VGLUT2-VTA-projecting neurons 1551, which is interesting insofar as the ventral pallidum has been regarded as the main source of GABA-mediated inhibitory postsynaptic potentials in VTA dopamine neurons /67/. The absence of spontaneous activity in about half of all mesencephalic dopamine neurons /16,66/ is thought to be due to the inhibitory input from the ventral pallidum, a structure in which most neurons exhibit high levels of spontaneous activity 44,45,67,96. The ventral pallidum-VTA pathway has been suggested to constitute part of a functional loop linking the hippocampus and VTA /44,67,108/. Insofar as activation of the hippocampus results in increased firing of accumbal /44/ and VTA /44,103,104,105/ neurons, a connectional model was proposed in which hippocampal outputs excite GABAergic neurons in the accumbens, which then inhibit GABAergic neurons in the ventral pallidum, thus releasing VTA dopamine neurons from tonic inhibition /44/. The disinhibited VTA in turn activates hippocampal neurons via a dopaminergic projection /106/. It has been suggested that this circuit plays an important role in regulating the entry of information into long-term memory /67, 106/. In addition, a neuronal circuit comprising GABAergic projections from the accumbens to the ventral pallidum and from the ventral pallidum to the VTA and a dopaminergic projection from the VTA to the accumbens may be crucial for the expression of locomotor activity elicited by psychostimulants /91/ and novelty /82/, insofar as a decrease of neurotransmission in either structure prevents psychostimulant-and novelty-induced locomotion without suppressing the activity of habituated animals /82/. Somewhat at odds with these connectional models is the recent finding of glutamatergic VTA-projecting neurons in the ventral pallidum /55/, which indicates that the wellknown GABAergic projection from the ventral pallidum /45,96/ may be tempered by a significant excitatory component. It will be interesting to learn whether GABAergic and glutamatergic VTAprojecting neurons in the ventral pallidum synapse differently onto dopaminergic and GABAergic neurons in the VTA, and thus act synergistically or antagonistically relative to each other, and whether glutamatergic and GABAergic neurons in the ventral pallidum target different specific sets of VTA output neurons projecting to distinct brain structures. The possibility exists that glutamatergic and GABAergic neurons in the ventral pallidum are involved in different functions. It has been reported recently that subsets of neurons in the ventral pallidum encode the hedonic value of natural sensory pleasure /159,160/. It remains to be determined whether the relevant ventral pallidal neurons are glutamatergic and/or GABAergic and whether they project to the VTA.
Other forebrain structures with VGLUT2-positive projections to the VTA are, in order of decreasing 'robustness', the medial preoptic area, nuclei of the medial hypothalamus (anterior hypothalamic area, paraventricular, ventromedial and posterior hypothalamic nuclei, tuber cinereum, dorsal hypothalamic area), medial septum, diagonal band and caudal septum (septofimbrial nucleus). Very few glutamatergic projections to the VTA originate in the claustrum/dorsal endopiriform nucleus, sublenticular and subcommissural extended amygdala and ventrolateral bed nucleus of the stria terminalis /55,60,61/. Little is known about the functional significance of VTA projections from these structures.
In the brainstem, the greatest accumulation of VGLUT2-expressing VTA-projecting^ neurons is scattered through the rostrocaudal extent of the periaqueductal and central gray /55/. Other brainstem structures that contain VGLUT2-expressing VTA-projecting neurons include, in order of decreasing numbers, the mesopontine reticular formation, laterodorsal (LDTg) and pedunculopontine (PPTg) tegmental nuclei, cuneiform nucleus, parabrachial nucleus, median raphe, and superior colliculus/55/ (Fig. 1) .
Of The projection from the LDTg to the VTA is reportedly involved in the initiation of behavioral sensitization to psychostimulants. Nelson et al. /II5/ reported that intra-LDTg injection of the glutamate receptor agonist AMPA causes a longerlasting glutamate release in the VTA and a greater dopamine release in the accumbens in amphetamine-sensitized than in control rats. The authors suggest that repeated amphetamine administration leads to an enhanced response of LDTg neurons to AMPA activation resulting in increased glutamate release in the VTA, and thus greater activation of mesoaccumbens neurons. These functional data are in good accord with anatomical data demonstrating that (i) glutamatergic neurons in the LDTg indeed project to the VTA 1551, and (ii) axons originating in the LDTg have asymmetrical (putative excitatory) contacts with dopaminergic mesoaccumbal neurons and symmetrical (inhibitory) contacts with GABAergic mesoaccumbal neurons /II9/, thus presumably exciting dopaminergic and inhibiting GABAergic VTA neurons that project to the accumbens. Consequently, the LDTg seems to be in a position to selectively increase accumbal dopamine release. In contrast, both asymmetrical and symmetrical synaptic contacts characterize LDTg inputs to GABAergic and dopaminergic VTA neurons projecting to the prefrontal cortex / 119/.
The PPTg is increasingly thought to have a key role in regulating conditioned responses of dopamine cells. In awake rats, extremely short latency phasic responses of PPTg neurons are tightly timelocked to auditory and visual stimuli /124/ with a clear bias toward auditory stimuli. This information appears to be relayed to dopamine neurons in the VTA, insofar as the phasic response of the VTA dopamine neurons to sensory stimuli is suppressed after inactivation of the PPTg. Although some glutamatergic VTA-projecting neurons are present in the PPTg, the PPTg-driven phasic increase in dopamine neuron firing may reflect activity in both mono-and polysynaptic pathways from the PPTg to the VTA, because (i) of the long latency between PPTg activation and the dopamine neuron response /124/, and (ii) only few glutamatergic neurons project from the PPTg to the VTA -far fewer than are present in, e.g., the LDTg or ventral pallidum /55/.
Insofar as PPTg neurons respond preferentially to auditory stimuli /124/, the possibility exists that different sensory modalities are conveyed to the VTA via different pathways. Indeed, information about visual stimuli appears to be relayed to VTA dopamine neurons via the deep layers of the superior colliculus /26,37/. Based on the few glutamatergic VTA-projecting neurons detected in the superior colliculus 1551 and the latency between superior colliculus activation and the response of dopamine neurons /37/ one might speculate that, similar to the PPTg, the information from the superior colliculus to the VTA is transferred via a small monosynaptic and a larger polysynaptic pathway.
Intra-VTA VGLUT2-positive terminals may also reflect local axon collaterals of VGLUT2-expressing neurons situated in the VTA /55.83.100, 182/. Glutamatergic neurons in the VTA subnuclei parabrachialis pigmentosus and paranigralis are almost exclusively non-dopaminergic /182/, whereas the midline nuclei, especially the rostral linear and interfascicular nuclei, contain neurons double labeled for VGLUT2 mRNA and tyrosine hydroxylase/100/.
VTA afferents containing VGLUT3
VTA-projecting neurons expressing VGLUT3 are located predominantly in the dorsal and, to a lesser extent, the median raphe 1551 (Fig. 1) . In contrast to VTA-projecting neurons expressing VGLUT2, which constitute about 20-35% of the VTA projections from the structures in which they are found, VGLUT3-expressing neurons represent about 65% of the dorsal raphe projection to the VTA 1551.
Because the majority of serotonergic neurons in the dorsal and median raphe expresses VGLUT3 /48,68,139/ and only a minor portion of VGLUT3-positive neurons in the dorsal and median raphe is non-serotonergic /139/, it is highly probable that serotonin and VGLUT3 are colocalized in the projection to the VTA, possibly in the same axon terminals. This hypothesis is supported by the observation that synapses by serotoninergic axon terminals in the VTA are predominantly of the asymmetrical (putative excitatory) type 1111. However, studying cultures of isolated raphe neurons, Fremeau at al. /48/ found that individual axonal processes often contain either VGLUT3 or serotonin, which led the authors to suggest that the release sites for serotonin and glutamate in the VTA may be segregated, a phenomenon earlier reported for dopamine and glutamate /75,149/. If VGLUT3 and serotonin are located in the same axon terminal in vivo, it would be interesting to learn whether the vesicular monoamine transporter (VMAT 2, which transports serotonin into synaptic vesicles) and VGLUT3 are present on the same vesicles and, thus, whether glutamate and serotonin are released simultaneously in the VTA. Because the median raphe also contains VGLUT2-expressing, VTA-projecting neurons, it is conceivable that a subset of median raphe neurons projecting to the VTA expresses VGLUT2, VGLUT3 and serotonin.
Scattered VGLUT3 VTA-projecting neurons are also situated, in order of decreasing numbers, in the central gray of the pons and medulla, lateral habenula and ventral bed nucleus of the stria terminalis (Fig. 1). 
Functional anatomy of glutamatergic projections to the VTA from cortical structures -VGLUTl
In contrast to VTA afferents of subcortical origin, the projection from the cortex to the VTA is almost entirely, and may be exclusively, glutamatergic /18,55,144/. VTA-projecting neurons expressing VGLUTl are situated predominantly in the deep layers of the medial and orbital prefrontal cortex. Densely packed VGLUTl-positive VTAprojecting neurons are observed in the prelimbic cortex, and, to a lesser extent, the dorsal peduncular, infralimbic, cingulate, medial orbital, ventral orbital, lateral orbital and agranular insular cortex, and the claustrum 1551. Axons of prefrontocortical neurons synapse onto GABAergic mesoaccumbens neurons and dopaminergic mesocortical neurons /18/. A very few VGLUT 1-positive VTA-projecting neurons are situated in the basolateral amygdaloid nucleus 1551, which is thought to be cortical-like in its organization Π 61.
When the numbers of VGLUT-positive VTAprojecting neurons in all structures are compared without reference to the type of VGLUT expressed, the prelimbic cortex contains the greatest number (about 17% of all VGLUT-positive VTA projecting neurons) followed by the lateral hypothalamus (about 7%), periaqueductal and central gray (about 6%) and dorsal raphe (about 5%). However, as stated above, many more VGLUT2-and VGLUT3-than VGLUTl-positive terminals are present in the VTA. Possible explanations for this apparent discrepancy include (i) not all RNA (visualized by in situ hybridization in the prefrontal cortex) is transcribed into protein (visualized by immunoreactivity in the VTA), (ii) fibers originating in the prefrontal cortex may arborize less densely in the VTA than do fibers from subcortical structures, and (iii) all inputs from subcortical structures combined outnumber the prefrontocortical afferents.
The prefrontal cortex reportedly plays an important role in the induction of burst activity of VTA dopamine neurons. Microinfusions of glutamate into the prefrontal cortex can increase burst firing of dopaminergic neurons /II3/, whereas chemical and physical inactivations of the medial prefrontal cortex profoundly inhibit bursting activity leaving a highly regular firing of dopamine neurons /151/. However, despite the direct projection of the prefrontal cortex to the VTA, electrophysiological data indicate that a multisynaptic pathway is involved in the prefronto-cortical modulation of VTA activity. Gariano and Groves /53/ reported that only about 5% of dopamine neurons exhibit bursting activity after electrical stimulation of the medial prefrontal cortex, in contrast to most dopamine neurons, which show an inhibition of spontaneous activity lasting up to several hundred milliseconds. Tong et al. /161 / demonstrated that 30.7% of dopamine neurons respond to 1 mA electrical stimulation of the prefrontal cortex with an initial excitation followed by inhibition, whereas 52.3% respond with an initial inhibition followed by excitation. Only 3% of recorded neurons showed only excitation /161/. Because the latencies of the excitation responses were too long to be monosynaptic and the initial inhibition most likely did not involve GABAergic neurons in the VTA /162/, these findings point to the importance of polysynaptic pathways in the modulation of VTA activity by the prefrontal cortex.
Recently, Shi /145/ reported a previously unrecognized firing pattern of VTA dopamine neurons. Specifically, a majority of them exhibits rhythmic bursting ('slow oscillations') in the absence of stimulation in anaesthetized rats. Inputs from the prefrontal cortex appear to play an important role in generating these oscillations, as both the amplitude of oscillations and numbers of dopamine neurons exhibiting them decreased following disconnection or chemical inactivation of the prefrontal cortex 1521. However, in contrast to what would be expected of a direct glutamatergic projection to VTA dopamine neurons, the active states of prefrontal cortex neurons coincide with decreases in firing of most VTA dopamine neurons examined, suggesting that part of the information transferred to dopamine neurons from the prefrontal cortex is relayed through inhibitory links /52/. Because some of the prefrontal cortex-coupled dopamine neurons also exhibited an in-phase relationship with prefrontal cortical neurons /52/, it is likely that the prefrontal cortex exerts its influence on dopamine neurons via both direct and indirect connections. This is in good accord with anatomical data demonstrating that the prefrontal cortex innervates both dopaminergic and GABAergic neurons in the VTA /18/ and electrophysiological results showing that VTA GABAergic neurons may inhibit their neighboring dopaminergic neurons 1921. Furthermore, the prefrontal cortex also innervates the accumbens, ventral pallidum, lateral hypothalamus and laterodorsal tegmental nucleus /15,142,143,167/, each of which projects to the VTA and to other VTA afferente /57,129/. Almost all of these structures contain glutamatergic and GABAergic VTA-projecting neurons, which may contribute to the complex effect the prefrontal cortex exerts on VTA dopamine neuron firing.
MODULATORS OF GLUTAMATERGIC TRANSMISSION IN THE VTA
In addition to glutamate, VTA afferents utilize a variety of neurotransmitters and neuromodulators, including GABA, acetylcholine, serotonin, noradrenaline, and neuropeptides, such as substance P, dynorphin, enkephalin, CART (cocaine-and amphetamine-regulated transcript), neurotensin, and corticotropin releasing factor /38,58,94,131, 185/. Peptides are generally considered modulators of synaptic communication. A number of them, including corticotropin-releasing factor (CRF), neurotensin and ghrelin, are known to modulate VTA glutamatergic transmission, and each of these, via a different mechanism, renders dopamine neurons more sensitive to intra-VTA glutamate release.
CRF stimulates glutamate release in the VTA in a manner which is itself modified by experience with cocaine. As mentioned in the Introduction, footshock stress causes CRF to be released in the VTA /169/. VTA infusion of CRF causes local glutamate release, local dopamine release, and reinstatement of cocaine-seeking in animals previously extinguished from intravenous selfadministration of cocaine but not in animals that have not been previously exposed to cocaine /169/. CRF modulates not only glutamate release, but also postsynaptic glutamatergic signaling by potentiating NMDA receptor-mediated synaptic transmission in dopamine neurons /164/. This potentiation, like the CRF-induced release of VTA glutamate seen in cocaine-trained animals /169/, is blocked by the CRF-receptor 2 antagonist and is dependent on CRF binding protein /164,170/. Thus, cocaine experience appears to alter both postsynaptic glutamate sensitivity /164/ and presynaptic glutamate release /165,169/, and CRF appears to have a role in each.
Ghrelin is a gastrointestinal and hypothalamic peptide that regulates food intake and energy homeostasis. Ghrelin binds to the growth hormone secretagogue receptor, which is expressed in about 60% of dopaminergic and 30% of GABAergic neurons in the VTA /1,190/. Most interestingly, the numbers of asymmetric (excitatory) synapses on mouse VTA dopamine neurons increased, whereas the numbers of symmetric (inhibitory) synapses decreased, within 90 minutes of an intraperitoneal injection of ghrelin III. Thus, ghrelin stimulates the rearrangement of the synaptic input to dopamine neurons in a manner that increases the probability of activation of these cells by other excitatory inputs. It is unknown how ghrelin reaches the VTA. Although it is transported across the blood-brain barrier, the major direction of transport, at least in mice, seems to be from the brain into the periphery /4/. Ghrelin-expressing neurons have been discovered in the hypothalamus in a region lodged between the lateral hypothalamic area, arcuate nucleus, paraventricular nucleus and ventromedial nucleus /30/, but it is unknown whether these hypothalamic ghrelin neurons project to the VTA. Nor are the origins known of the excitatory inputs which are altered by ghrelin /1 /.
The neurotensinergic innervation in the VTA is among the densest observed there /58,94,185/ and modulates the firing of dopaminergic neurons. High concentrations of neurotensin activate dopaminergic neurons by opening non-selective cation channels /23,40,90,147/, whereas low concentrations decrease dopamine D2 receptor-mediated autoinhibition, thereby causing a positive shift in the membrane potential of VTA dopamine neurons /41,172/ and increasing dopaminergic neuronal excitability. Given the great abundance of neurotensin binding sites in the VTA /32,132,154/, neurotensin may modulate a large portion of dopaminergic neurons. Neurotensinergic neurons projecting to the VTA are situated predominantly in the lateral-preoptic-rostral-lateral hypothalamic continuum (LPH) and medial preoptic area and to a lesser extent in many other brain areas, including the nucleus accumbens shell, dorsal raphe, and laterodorsal and pedunculopontine tegmental nuclei /58Λ The neurotensinergic innervation is remarkably resistant to chemical and mechanical lesions that deplete its cells of origin 1591, indicating a high adaptability of the system. This adaptability, however, may be disturbed following administrations of psychostimulants. Dopaminergic activation by psychostimulants causes ari increase of neurotensin expression in the striatum, including the accumbens shell /8,9,54/, where the increase appears to involve selectively neurons that project to the VTA /58/. Since neurotensin can shift the excitability of dopamine neurons, the enhanced release of neurotensin in the VTA following methamphetamine administration /184/ may lead to a vicious circle whereby dopamine neurons are activated, resulting in increased dopamine release in the nucleus accumbens, which results in increased neurotensin expression in VTA-projecting neurons, increased release of neurotensin in the VTA, increased excitability of dopamine neurons, and so forth. This may produce an extended period during which dopaminergic neurons are more susceptible to glutamatergic transmission, which may contribute to, facilitate or 'lock in' neuroadaptive changes associated with psychostimulant drug addiction. Indeed, Panayi et al. /125/ observed that injection of the neurotensin-receptor antagonist SR 142948A into the VTA can markedly attenuate the induction of behavioral sensitization to amphetamine.
Thus, the potentiation of glutamate release by upregulating NMDA receptors (CRF), rearranging the synaptic input of dopamine neurons (ghrelin) and partially depolarizing postsynaptic membrane potential (neurotensin) can render dopamine neurons more sensitive to glutamatergic activation.
THE INTEGRATIVE NATURE OF THE VTA AND ITS GLUTAMATERGIC AFFERENTS
The widespread distribution of CNS glutamatergic VTA-projecting neurons indicates that information about various and diverse stimuli representing all sensory modalities, as well as multimodal information in associational structures, such as the prefrontal cortex and hypothalamus, can be conveyed efficiently to the VTA via glutamatergic inputs. An important feature of VTA afferents is that structures projecting to the VTA also project to each other 1511. For example, the accumbens, in addition to projecting to the VTA, innervates the ventral pallidum, lateral preoptic area, and lateral hypothalamus /70,186,187/, each of which also sends strong projections to the VTA /57,129/. The lateral hypothalamus, in addition to innervating the VTA, also projects strongly to the lateral habenula, periaqueductal gray, dorsal raphe, and parabrachial nucleus /102,138,152/, each of which innervates the VTA /57,129/, and so on, suggesting that the afferents of the VTA constitute an interconnected network, in which they may influence the VTA and each other. Importantly, almost all parts of the interconnected network contain at least some glutamatergic neurons. Thus, this interconnected network of VTA afferents may provide mechanisms to amplify (or dampen) signals, thereby focusing related inputs and separating and distinguishing dissimilar inputs.
Insofar as VTA afferents arborize sparsely /57/ and terminate predominantly on the long, sparsely branching dendrites characteristic of VTA neurons /130/, concurrent activation of several glutamatergic afferents may have additive effects on, or may even be necessary for, dopamine neuron firing. The recent findings by Lodge and Grace /108/, demonstrating that synchronous activity of glutamatergic afferents from different sources can result in additive increases in dopamine cell firing, are consistent with this conceptual framework. As mentioned above, the pedunculopontine tegmental nucleus plays an important role in conveying sensory stimuli to the VTA /124/. Most interestingly, although the PPTg responds to sensory stimuli irrespective of whether or not the sensory stimuli predict a reward /124/, dopaminergic VTA neurons respond mainly to sensory stimuli that predict reward. Pan and Hyland /124/ proposed that in addition to the PPTg input, other inputs ("reward-information-bearing pathways") are necessary to activate VTA dopamine neurons. One way to activate several afferents is via the just described network of VTA afferents.
In contrast to sensory stimuli that are conveyed to the VTA via (most likely glutamatergic) afferents, it is largely not known whether (and if so, which) glutamatergic projections to the VTA are involved in the effects of drugs of abuse. Drugs of abuse can release glutamate locally without activating the glutamatergic cells projecting to the VTA. For example, nicotine releases glutamate by activating alpha7 nicotinic acetyl choline receptors (nAChR) located on glutamatergic terminals in the VTA. This glutamate release together with a shortlasting direct depolarization of VTA dopamine neurons by postsynaptic nAChR is sufficient to induce long-term potentiation of excitatory synaptic transmission on dopaminergic neurons /111/. Furthermore, amphetamine-induced glutamate efflux in the VTA may be due to the reversal of the glutamate transporter expressed by astrocytes in the VTA /98,180/ and CRF releases glutamate from glutamatergic terminals presumably without activating the neurons of origin in stress-induced reinstatement /169/. However, the observations that re-exposure to cues previously associated with drug taking can lead to glutamate release in the VTA /183/ and to reinstatement of drug seeking /12/ strongly indicate that activation of glutamatergic neurons projecting to the VTA indeed play an important role in the effects of drugs of abuse. It will be important to find out which sets of glutamatergic afferents are involved in cue-induced reinstatement and whether they are identical to the afferents conveying information about natural rewards.
SUMMARY AND CONCLUSIONS
Glutamatergic afferents of the VTA are crucial for the normal functioning of the VTA and play an important role in the pathophysiology of drug addiction. Glutamatergic neurons innervating the VTA are present in the majority of structures that project to the VTA. Projection from the prefrontal cortex is essentially entirely glutamatergic, while subcortical glutamatergic neurons innervating the VTA intermingle with non-glutamatergic, most likely GABAergic and/or peptidergic VTA-projecting neurons, which is consistent with a wide range of potential subcortical influences on VTA activity. VOLUME 19, NO. 4-5,2008 The organization of glutamatergic afferents permits a short-latency activation of VTA neurons from many structures and suggests that the activity of the VTA reflects the ongoing activities of various combinations of its afferents. Thus, the VTA most likely functions by integrating multifarious bits of information /57,116/ and not by just relaying already processed information. Here, we suggested that the glutamatergic afferents of the VTA comprise an interconnected network in which they influence each other and the VTA. The functional significance of the network is not yet clear but one could speculate that it can amplify (or dampen) signals and that it is capable of encoding specific information about the stimuli conveyed to the VTA. Depending on which sets of afferents are concurrently activated and which neuromodulators are recruited, information about specific stimuli can be conveyed to the VTA and may result in the activation of subsets of VTA neurons.
Exciting progress has been made uncovering the effects of glutamate in the VTA and of the resulting dopamine release in the target areas of dopaminergic neurons. It is now important to find out how information about different stimuli is conveyed to the VTA and what role is played by the interconnected network of glutamatergic afferents. It is also important to distinguish the effects that drugs of abuse exert on glutamatergic afferents from those reflecting direct pharmacological actions in the VTA in order to better understand the neural processes driven by drugs of abuse. 
